CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Delisting notice
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Regulation FD disclosure
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K Report Annual Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Regulation FD disclosure
- 424B3 Offering Prospectus
- 8-K Event Results of operations · Other events
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Agreement ended
- 424B3 Offering Prospectus
Page 3 of 26 · 506 filings